Navidea Biopharmaceuticals Appoints Joshua Wilson to the Board of Directors; Announces Dates Related to its 2022 Annual Meeting of Stockholders
30.09.2022 - Navidea Biopharmaceuticals, Inc. (NYSE American: NAVB) (“Navidea” or the “Company”), a company focused on the development of precision immunodiagnostic agents and immunotherapeutics, today announced the appointment of Joshua (“Josh”) Wilson to its ... Seite 1
United States Regis University Rolling Hills First Western Trust Bank National Western Stock Show Family Office Executive Of Central Resources Inc
Source: wallstreet-online.de